Passive electrical monitoring and localization of fluid leakages from wells by Revil, A., Mao, D., Haas, A.K., Karaoulis, M., Frash, L.

Get full text

Arthroscopic Partial Meniscectomy Was Not More Effective Than Physical Therapy for Meniscal Tear and Knee Osteoarthritis by Katz, J.N, Brophy, R.H, Chaisson, C.E, de Chaves, L, Cole, B.J, Dahm, D.L, Donnell-Fink, L.A, Guermazi, A, Haas, A.K, Jones, M.H, Levy, B.A, Mandl, L.A, Martin, S.D, Marx, R.G, Miniaci, A, Matava, M.J, Palmisano, J, Reinke, E.K, Richardson, B.E, Rome, B.N, Safran-Norton, C.E, Skoniecki, D.J, Solomon, D.H, Smith, M.V, Spindler, K.P, Stuart, M.J, Wright, J, Wright, R.W, Losina, E

Get full text

High-Yield Methods for Accurate Two-Alternative Visual Psychophysics in Head-Fixed Mice by Burgess, Christopher P., Lak, Armin, Steinmetz, Nicholas A., Zatka-Haas, Peter, Bai Reddy, Charu, Jacobs, Elina A.K., Linden, Jennifer F., Paton, Joseph J., Ranson, Adam, Schröder, Sylvia, Soares, Sofia, Wells, Miles J., Wool, Lauren E., Harris, Kenneth D., Carandini, Matteo

Get full text

Nanoparticle treatment inhibits macrophage polarization towards the anti-inflammatory M2 subset by Fuchs, A.K, Syrovets, T, Loos, C, Haas, K, Simmet, T

Get full text

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry by Beyer-Westendorf, J, Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Get full text

Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate? by Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Beyer-Westendorf, J, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Get full text

195 - Nanoparticle treatment inhibits macrophage polarization towards the anti-inflammatory M2 subset by Fuchs, A.K., Syrovets, T., Loos, C., Haas, K., Simmet, T.

Get full text

Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registr... by Himmelreich, J.C.L, Virdone, S, Camm, A.J, Harskamp, R.E, Pieper, K.S, Fox, K.A.A, Bassand, J.-P, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Get full text

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry by Virdone, S, Himmelreich, J.C.L, Pieper, K.S, Camm, A.J, Bassand, J.-P, Fox, K.A.A, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Kayani, G, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Get full text

Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry by Bassand, J, Virdone, S, Verheugt, F.W.A, Camm, A.J, Cools, F, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Hacke, W, Kayani, G, Misselwitz, F, Pieper, K.S, Turpie, A.G.G, Kakkar, A.K

Get full text

Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria by Himmelreich, J.C.L, Virdone, S, Camm, A.J, Harskamp, R.E, Pieper, K.S, Fox, K.A.A, Bassand, J.-P, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Get full text

The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry by Camm, C.J.F, Camm, A.J, Virdone, S, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Get full text

Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry by Cools, F, Johnson, D, Pieper, K.S, Camm, A.J, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Kakkar, A.K

Get full text

Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry by Apenteng, P, Fitzmaurice, D.A, Virdone, S, Camm, A.J, Fox, K.A.A, Bassand, J.-P, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Get full text

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF by Camm, A.J, Steffel, J, Virdone, S, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Get full text

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement by ERIKSSON, B. I., BORRIS, L., DAHL, O. E., HAAS, S., HUISMAN, M. V., KAKKAR, A. K., MISSELWITZ, F., KÄLEBO, P.

Get full text

The COMPASS experiment at CERN by Albrecht, E., Alexeev, G.D., Anosov, V.A., Barth, J., Bisplinghoff, J., Braem, A., Bressan, A., Burtin, E., Bytchkov, V.N., Chapiro, A., Chiosso, M., Cicuttin, A., Colavita, A.A., Crespo, M.L., Cristaudo, P., Dalla Torre, S., Dhara, L., Dolgopolov, A.V., Donskov, S.V., Eyrich, W., Fauland, P., Finger, M., Friedrich, J.M., Frolov, V., Fuchs, U., Garfagnini, R., Gautheron, F., Gheller, J.M., Giorgi, M., Grube, B., Heinsius, F.H., Heß, C., von Hodenberg, M., Kalinnikov, V., Kastaun, W., Ketzer, B., Khaustov, G.V., Khokhlov, Yu.A., Klein, F., Komissarov, E.V., Konorov, I., Konstantinov, V.F., Kramer, D., Kubart, J., Leberig, M., Lehmann, A., Levorato, S., Liska, T., Manuilov, I.V., Marchand, C., Marzec, J., Matsuda, T., Matthiä, D., Mielech, A., Mota, F., Mutter, A., Nähle, O., Neyret, D., Nikolaenko, V.I., Panebianco, S., Paul, S., Piragino, G., Pochodzalla, J., Pontecorvo, G., Popov, A.A., Procureur, S., Rajotte, J.-F., Razaq, I., Reggiani, D., Rocco, E., Rondio, E., Ropelewski, L., Sandacz, A., Santos, H., Sapozhnikov, M.G., Schill, C., Schmidt, T., Schmitt, L., Seeharsch, D., Seimetz, M., Shaligin, A., Shevchenko, O.Yu, Siebert, H.-W., Sissakian, A.N., Stolarski, M., Sulej, R., Takabayashi, N., Tchalishev, V.V., Teufel, A., Tkatchev, L.G., Urban, J., Valbuena, R., Vlassov, N.V., Vossen, A., Webb, R., Wiedner, U., Wiślicki, W., Zavertyaev, M., Zhao, J., Ziegler, R.

Get full text

Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines by Kakkar, A. K., Davidson, B. L., Haas, S. K.

Get full text

High-speed AJL8/APC polymer modulator by Michalak, R.J., Ying-Hao Kuo, Nash, F.D., Szep, A., Caffey, J.R., Payson, P.M., Haas, F., McKeon, B.F., Cook, P.R., Brost, G.A., Jingdong Luo, Jen, A.K.-Y., Dalton, L.R., Steier, W.H.

Get full text

Why do clinicians prescribe oral anticoagulation in patients with atrial fibrillation despite a low CHA2DS2-VASc score? by Martin, A., Verbrugge, F., Siegal, D., Fiarresga, A., Pieper, K., Camm, J., Fox, K.K.A., Bassand, J.P., Haas, S., Goldhaber, S.Z., Kakkar, A.K.

Get full text